Up-regulated  	Up-regulated  	 NNP	O
14-3-3β  	14-3-3β  	 NNP	O
and  	and  	 CC	O
14-3-3ζ  	14-3-3ζ  	 CD	O
proteins  	proteins  	 NNS	O
in  	in  	 IN	O
prefrontal  	prefrontal  	 JJ	B-NP
cortex  	cortex  	 NN	I-NP
of  	of  	 IN	I-NP
subjects  	subjects  	 NNS	I-NP
with  	with  	 IN	O
schizophrenia 	schizophrenia 	 NN	O
:  	:  	 :	O
effect  	effect  	 NN	O
of  	of  	 IN	O
psychotropic  	psychotropic  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
14-3-3  	14-3-3  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
family  	family  	 NN	O
of  	of  	 IN	O
conserved  	conserved  	 JJ	O
regulatory  	regulatory  	 JJ	B-NP
proteins  	proteins  	 NNS	I-NP
that  	that  	 IN	O
bind  	bind  	 NN	O
to  	to  	 TO	O
a  	a  	 DT	O
multitude  	multitude  	 NN	O
of  	of  	 IN	O
functionally  	functionally  	 JJ	O
diverse  	diverse  	 JJ	B-NP
signalling  	signalling  	 JJ	I-NP
proteins 	proteins 	 NNS	I-NP
.  	.  	 .	O
Various  	Various  	 JJ	B-NP
genetic  	genetic  	 JJ	I-NP
studies  	studies  	 NNS	I-NP
and  	and  	 CC	O
gene  	gene  	 NN	B-NP
expression  	expression  	 NN	I-NP
and  	and  	 CC	O
proteomic  	proteomic  	 JJ	B-NP
analyses  	analyses  	 NNS	I-NP
have  	have  	 VBP	O
involved  	involved  	 VBN	O
14-3-3  	14-3-3  	 CD	O
proteins  	proteins  	 NNS	O
in  	in  	 IN	O
schizophrenia  	schizophrenia  	 NN	B-NP
( 	( 	 -LRB-	O
SZ 	SZ 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
On  	On  	 IN	O
the  	the  	 DT	O
other  	other  	 JJ	O
hand 	hand 	 NN	O
,  	,  	 ,	O
studies  	studies  	 NNS	O
about  	about  	 IN	O
the  	the  	 DT	O
status  	status  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
proteins  	proteins  	 NNS	O
in  	in  	 IN	O
major  	major  	 JJ	O
depressive  	depressive  	 JJ	B-NP
disorder  	disorder  	 NN	I-NP
( 	( 	 -LRB-	O
MD 	MD 	 NNP	O
)  	)  	 -RRB-	O
are  	are  	 VBP	O
still  	still  	 RB	O
missing 	missing 	 VBG	O
.  	.  	 .	O
Immunoreactivity  	Immunoreactivity  	 JJ	B-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
cytosolic  	cytosolic  	 JJ	O
14-3-3β  	14-3-3β  	 NN	O
and  	and  	 CC	O
14-3-3ζ  	14-3-3ζ  	 CD	O
proteins  	proteins  	 NNS	O
were  	were  	 VBD	O
evaluated  	evaluated  	 VBN	O
by  	by  	 IN	O
Western  	Western  	 JJ	O
blot  	blot  	 NN	O
in  	in  	 IN	O
prefrontal  	prefrontal  	 JJ	B-NP
cortex  	cortex  	 NNS	I-NP
( 	( 	 -LRB-	O
PFC 	PFC 	 NNP	B-NP
)  	)  	 -RRB-	O
of  	of  	 IN	O
subjects  	subjects  	 NNS	B-NP
with  	with  	 IN	O
schizophrenia  	schizophrenia  	 NN	B-NP
( 	( 	 -LRB-	O
SZ 	SZ 	 NNP	B-NP
;  	;  	 :	O
n=22 	n=22 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
subjects  	subjects  	 NNS	B-NP
with  	with  	 IN	O
major  	major  	 JJ	O
depressive  	depressive  	 JJ	B-NP
disorder  	disorder  	 NN	I-NP
( 	( 	 -LRB-	O
MD 	MD 	 NNP	O
;  	;  	 :	O
n=21 	n=21 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
age- 	age- 	 JJ	O
,  	,  	 ,	O
gender-  	gender-  	 JJ	B-NP
and  	and  	 CC	O
postmortem  	postmortem  	 JJ	B-NP
delay-matched  	delay-matched  	 JJ	I-NP
control  	control  	 NN	I-NP
subjects  	subjects  	 NNS	I-NP
( 	( 	 -LRB-	O
n=52 	n=52 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
modulation  	modulation  	 NN	B-NP
of  	of  	 IN	O
14-3-3β  	14-3-3β  	 NNP	O
and  	and  	 CC	O
14-3-3ζ  	14-3-3ζ  	 CD	O
proteins  	proteins  	 NNS	O
by  	by  	 IN	O
psychotropic  	psychotropic  	 JJ	B-NP
medication  	medication  	 NN	I-NP
was  	was  	 VBD	O
also  	also  	 RB	O
assessed 	assessed 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
both  	both  	 DT	O
proteins  	proteins  	 NNS	O
in  	in  	 IN	O
SZ  	SZ  	 NNP	B-NP
subjects  	subjects  	 NNS	I-NP
with  	with  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
matched  	matched  	 VB	B-NP
control  	control  	 NN	I-NP
subjects  	subjects  	 NNS	I-NP
showed  	showed  	 VBD	O
increased  	increased  	 VBN	O
14-3-3β  	14-3-3β  	 NNP	O
( 	( 	 -LRB-	O
Δ=33±10 	Δ=33±10 	 NNP	O
% 	% 	 NN	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
14-3-3ζ  	14-3-3ζ  	 NNP	O
( 	( 	 -LRB-	O
Δ=29±6 	Δ=29±6 	 NNP	O
% 	% 	 NN	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
)  	)  	 -RRB-	O
immunoreactivity  	immunoreactivity  	 NN	B-NP
in  	in  	 IN	O
antipsychotic-free  	antipsychotic-free  	 JJ	B-NP
but  	but  	 CC	O
not  	not  	 RB	O
in  	in  	 IN	O
antipsychotic-treated  	antipsychotic-treated  	 NNP	B-NP
SZ  	SZ  	 NNP	I-NP
subjects 	subjects 	 NNS	I-NP
.  	.  	 .	O
Immunoreactivity  	Immunoreactivity  	 JJ	B-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
14-3-3β  	14-3-3β  	 NNP	O
and  	and  	 CC	O
14-3-3ζ  	14-3-3ζ  	 NNP	O
were  	were  	 VBD	O
not  	not  	 RB	O
altered  	altered  	 VBN	O
in  	in  	 IN	O
MD  	MD  	 NNP	O
subjects 	subjects 	 NNS	B-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
show  	show  	 VBP	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
up-regulation  	up-regulation  	 NN	B-NP
of  	of  	 IN	O
14-3-3β  	14-3-3β  	 NNP	O
and  	and  	 CC	O
14-3-3ζ  	14-3-3ζ  	 CD	O
proteins  	proteins  	 NNS	O
in  	in  	 IN	O
PFC  	PFC  	 NNP	B-NP
of  	of  	 IN	I-NP
SZ  	SZ  	 NNP	I-NP
subjects  	subjects  	 NNS	I-NP
and  	and  	 CC	O
suggest  	suggest  	 VB	O
a  	a  	 DT	O
possible  	possible  	 JJ	O
down-regulation  	down-regulation  	 NN	B-NP
of  	of  	 IN	O
both  	both  	 DT	O
proteins  	proteins  	 NNS	O
by  	by  	 IN	O
antipsychotic  	antipsychotic  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
.  	.  	 .	O
